These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 23746480

  • 41. Clinical significance of high-sensitivity cardiac troponin T in patients with dilated cardiomyopathy.
    Baba Y, Kubo T, Yamanaka S, Hirota T, Tanioka K, Yamasaki N, Sugiura T, Kitaoka H.
    Int Heart J; 2015 May 13; 56(3):309-13. PubMed ID: 25912901
    [Abstract] [Full Text] [Related]

  • 42. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
    Dumont CA, Monserrat L, Soler R, Rodríguez E, Fernández X, Peteiro J, Bouzas B, Piñón P, Castro-Beiras A.
    Rev Esp Cardiol; 2007 Jan 13; 60(1):15-23. PubMed ID: 17288951
    [Abstract] [Full Text] [Related]

  • 43. Measurements of baseline and follow-up concentrations of cardiac troponin-T and brain natriuretic peptide in patients with heart failure from various etiologies.
    Taniguchi R, Sato Y, Nishio Y, Kimura T, Kita T.
    Heart Vessels; 2006 Nov 13; 21(6):344-9. PubMed ID: 17143708
    [Abstract] [Full Text] [Related]

  • 44. The kinetics of highly sensitive cardiac troponin T release after prolonged treadmill exercise in adolescent and adult athletes.
    Tian Y, Nie J, Huang C, George KP.
    J Appl Physiol (1985); 2012 Aug 13; 113(3):418-25. PubMed ID: 22653984
    [Abstract] [Full Text] [Related]

  • 45. Comparison of novel pro-BNP(1-108) and standard BNP assays in heart failure patients.
    Miller WL, Grill DE, Jaffe AS.
    Clin Chim Acta; 2012 May 18; 413(9-10):920-6. PubMed ID: 22366122
    [Abstract] [Full Text] [Related]

  • 46. Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trials.
    Masson S, Anand I, Favero C, Barlera S, Vago T, Bertocchi F, Maggioni AP, Tavazzi L, Tognoni G, Cohn JN, Latini R, Valsartan Heart Failure Trial (Val-HeFT) and Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca–Heart Failure (GISSI-HF) Investigators.
    Circulation; 2012 Jan 17; 125(2):280-8. PubMed ID: 22139751
    [Abstract] [Full Text] [Related]

  • 47. Aged-related increase of high sensitive Troponin T and its implication in acute myocardial infarction diagnosis of elderly patients.
    Olivieri F, Galeazzi R, Giavarina D, Testa R, Abbatecola AM, Çeka A, Tamburrini P, Busco F, Lazzarini R, Monti D, Franceschi C, Procopio AD, Antonicelli R.
    Mech Ageing Dev; 2012 May 17; 133(5):300-5. PubMed ID: 22446505
    [Abstract] [Full Text] [Related]

  • 48. Combined evaluation of coronary artery disease and high-sensitivity cardiac troponin T for prediction of adverse events in patients with hypertrophic cardiomyopathy.
    Liao H, Tan HC, Wang Z, Chen X, He Y, He S.
    BMC Cardiovasc Disord; 2021 Jul 03; 21(1):325. PubMed ID: 34217206
    [Abstract] [Full Text] [Related]

  • 49. Evaluating the utility of circulating biomarkers of collagen synthesis in hypertrophic cardiomyopathy.
    Ellims AH, Taylor AJ, Mariani JA, Ling LH, Iles LM, Maeder MT, Kaye DM.
    Circ Heart Fail; 2014 Mar 01; 7(2):271-8. PubMed ID: 24481111
    [Abstract] [Full Text] [Related]

  • 50. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time.
    Miller WL, Hartman KA, Burritt MF, Grill DE, Rodeheffer RJ, Burnett JC, Jaffe AS.
    Circulation; 2007 Jul 17; 116(3):249-57. PubMed ID: 17592074
    [Abstract] [Full Text] [Related]

  • 51. Prognostic values of highly sensitive cardiac troponin T and B-type natriuretic peptide for clinical features in hypertrophic obstructive cardiomyopathy: a cross-sectional study.
    Nakamura S, Takano H, Matsuda J, Chinen D, Kitamura M, Murai K, Asai K, Yasutake M, Takayama M, Shimizu W.
    BMJ Open; 2014 Sep 17; 4(9):e005968. PubMed ID: 25231494
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy.
    Prinz C, Schwarz M, Ilic I, Laser KT, Lehmann R, Prinz EM, Bitter T, Vogt J, van Buuren F, Bogunovic N, Horstkotte D, Faber L.
    Can J Cardiol; 2013 Mar 17; 29(3):358-63. PubMed ID: 22749647
    [Abstract] [Full Text] [Related]

  • 58. Magnetic resonance imaging of myocardial injury and ventricular torsion after marathon running.
    Hanssen H, Keithahn A, Hertel G, Drexel V, Stern H, Schuster T, Lorang D, Beer AJ, Schmidt-Trucksäss A, Nickel T, Weis M, Botnar R, Schwaiger M, Halle M.
    Clin Sci (Lond); 2011 Feb 17; 120(4):143-52. PubMed ID: 20815809
    [Abstract] [Full Text] [Related]

  • 59. Highly sensitive cardiac troponin T in heart failure: comparison with echocardiographic parameters and natriuretic peptides.
    Kusumoto A, Miyata M, Kubozono T, Ikeda Y, Shinsato T, Kuwahata S, Fujita S, Takasaki K, Yuasa T, Hamasaki S, Tei C.
    J Cardiol; 2012 Mar 17; 59(2):202-8. PubMed ID: 22266455
    [Abstract] [Full Text] [Related]

  • 60. Significance of plasma levels of N-terminal Pro-B-type natriuretic peptide on left ventricular remodeling in non-obstructive hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene.
    Magga J, Sipola P, Vuolteenaho O, Risteli J, Jääskeläinen P, Peuhkurinen K, Kuusisto J.
    Am J Cardiol; 2008 Apr 15; 101(8):1185-90. PubMed ID: 18394456
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.